Post-Translational Control: The Next Step in Synthetic Circuits

Researchers engineer a protease-mediated post-translational path faster than gene switches for processes that need to happen quickly, such as insulin release.

Deanna MacNeil, PhD headshot
| 3 min read
Researchers engineer a protease-mediated post-translational path faster than gene switches for processes that need to happen quickly, such as insulin release.

© ISTOCK.COM

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share
The Golgi with budding vesicles involved in protein secretion.

Strategies to program cellular behaviors are central in synthetic biology. Scientists have developed many synthetic genetic circuits that allow engineered cells to produce therapeutic agents on demand in response to specific stimuli, such as oncoproteins (e.g., mutant KRAS), chemicals (e.g., caffeine), and physical stimuli (e.g., light). However, most circuits are based on gene switches that control transcription from a synthetic expression unit. This delays downstream signal transduction and as a result, transcription-based circuits are too slow for some therapeutic applications.1-3

“Killing a virus-infected cell, needing insulin to get your blood glucose to the right level…that all needs to happen extremely fast and gene switches are just too slow…[They go] through transcription, translation, protein secretion, and that takes some time,” explained Martin Fussenegger, professor of biotechnology and bioengineering at the University of Basel. In a study published in NAR, Fussenegger’s team developed a programmable synthetic circuit to control secretion of a protein of interest after translation.1

Synthetic circuits that rely on post-translational control, mediated by engineered proteins, offer a more rapid approach than transcription-based gene switches. Fussenegger’s team generated a protease-mediated circuit they named POSH (post-translational switch). This circuit involves the transmembrane domain of a cleavable endoplasmic reticulum (ER) retention signal fused to a protein of interest. The system produces the desired protein, which stays in the ER under resting conditions due to the retention signal. The POSH platform depends on a customizable inducer-sensitive protease to release the protein of interest from the ER. The protease is expressed in two parts, which combine in the presence of an inducer to cleave the ER retention signal of the chimeric protein. The protein of interest is then released from the ER and undergoes trafficking to the Golgi for protein secretion. “It's a very clever design,” said Mads Kaern, associate professor in the Department of Cellular and Molecular Medicine at University of Ottawa, who was not involved in the study. “You're using cells as pharmacies, basically…you trick the cells into producing the medicine that the body needs, and then you're controlling when and where and how much is released.”

Killing a virus-infected cell, needing insulin to get your blood glucose to the right level…that all needs to happen extremely fast and gene switches are just too slow.
- Martin Fussenegger, University of Basel

Fussenegger’s team showed that they could control POSH with a variety of stimuli, including chemical inducers, light, and electrostimulation. They also demonstrated the versatility of this circuit to program protein secretion in several mammalian cell lines. The researchers first characterized POSH control in HEK293T cells, and then established inducible protein secretion in cancer-derived cells lines (HeLa and HEPG2) and a non-human mammalian cell line (COS-7). This array of effective stimuli and applicable systems emphasized that POSH is an adaptable, controllable platform for a range of scientific avenues. “[We were] hoping that others would find what they need to use this technology in their particular research,” Fussenegger explained.

POSH is not the first reported protease-mediated post-translational synthetic circuit. Fussenegger’s study follows publications on programmable systems by research groups at Stanford University and the University of Ljubljana—all three groups established robust synthetic circuits for controlling cellular behavior in culture.2,3 Fussenegger’s team took their system one step further, into a rodent model of type 1 diabetes. They validated their platform in vivo as a cell therapy by implanting POSH-engineered HEK293T cells into the mice, and as a gene therapy by injecting mice with a plasmid coding for POSH components. The researchers then injected mice with abscisic acid to induce insulin secretion. This led to a prolonged increase of insulin levels in the blood stream, showing that POSH can be used for on-demand secretion of insulin to normalize hyperglycemia in type 1 diabetic mice.

This work positions post-translational circuits like POSH for potential therapeutic avenues in the future treatment of hormone secretion-based conditions such as diabetes. POSH features a faster response than transcription-based gene switches, and is a valuable tool for post-translational control and programming of cell behavior in culture and beyond.

  1. M. Mansouri et al., “Design of programmable post-translational switch control platform for on-demand protein secretion in mammalian cells,” NAR, gkac916, 2022.
  2. A.E. Vlahos et al., “Protease-controlled secretion and display of intercellular signals,” Nat Commun, 13(1):912, 2022.
  3. A. Praznik et al., “Regulation of protein secretion through chemical regulation of endoplasmic reticulum retention signal cleavage,” Nat Commun, 13(1):1323, 2022.
Research Resources logo

Keywords

Meet the Author

  • Deanna MacNeil, PhD headshot

    Deanna MacNeil, PhD

    Deanna earned their PhD in cellular biology from McGill University in 2020 and has a professional background in medical writing. They are an associate science editor at The Scientist.
Share
You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
A greyscale image of cells dividing.
March 2025, Issue 1

How Do Embryos Know How Fast to Develop

In mammals, intracellular clocks begin to tick within days of fertilization.

View this Issue
Discover the history, mechanics, and potential of PCR.

Become a PCR Pro

Integra Logo
3D rendered cross section of influenza viruses, showing surface proteins on the outside and single stranded RNA inside the virus

Genetic Insights Break Infectious Pathogen Barriers

Thermo Fisher Logo
A photo of sample storage boxes in an ultra-low temperature freezer.

Navigating Cold Storage Solutions

PHCbi logo 
The Immunology of the Brain

The Immunology of the Brain

Products

Sapio Sciences

Sapio Sciences Makes AI-Native Drug Discovery Seamless with NVIDIA BioNeMo

DeNovix Logo

New DeNovix Helium Nano Volume Spectrophotometer

Olink Logo

Olink® Reveal: Accessible NGS-based proteomics for every lab

Olink logo
Zymo Logo

Zymo Research Launches the Quick-16S™ Full-Length Library Prep Kit